|
시장보고서
상품코드
2058385
마취 가스 시장 : 제품 유형별, 마취 가스별, 최종사용자별, 지역별Anesthesia Gases Market, By Product Type, By Anesthesia Gases, By End User, By Geography |
||||||
가격
※ 부가세 별도
한글목차
영문목차
※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.
마취 가스 시장은 2026년에 21억 1,050만 달러로 추정되며, 2033년까지 27억 1,060만 달러에 달할 것으로 예상됩니다. 2026년부터 2033년까지 CAGR 3.9%로 성장할 것으로 전망됩니다.
| 보고서 범위 | 보고서 상세 | ||
|---|---|---|---|
| 기준 연도: | 2025년 | 2026년 시장 규모: | 21억 1,050만 달러 |
| 과거 데이터 기간: | 2020-2024년 | 예측 기간: | 2026-2033년 |
| 2026년부터 2033년까지 예측 기간 CAGR: | 3.90% | 2033년 시장 규모 예측: | 27억 1,060만 달러 |
흡입 마취제로도 알려진 마취 가스(이소플루란, 세보플루란, 데스플루란, 할로탄, 아산화질소 등)은 수술 전후 기간에 수술 전 진정 요법의 주요 치료법으로, 또한 정맥 내(IV) 마취제(미다졸람이나 프로포폴 등)의 보조적인 마취 유지제로 투여됩니다.
시장 역학
만성 질환 유병률의 증가, 고령 인구 증가, 마취 가스 수요 증가, 수술 중 마취 사용 증가, 그리고 전 세계 수술 건수 증가는 예측 기간 동안 전 세계 마취 가스 시장의 성장을 견인할 것으로 예상되는 주요 요인입니다.
예를 들어, 2022년 2월, 세다나 메디컬(Sedana Medical)은 독일에서 세다콘다(이소플루란)의 출시를 발표했습니다. 의료기기 '세다콘다 ACD(마취제 절약 장치)'를 통해 투여되는 세다콘다(이소플루란)는 중환자 치료 중 사용이 승인된 유일한 흡입 진정 요법입니다. 세다콘다는 2021년 7월에 유럽의 DCP 승인을 획득했습니다.
본 조사의 주요 특징
- 본 조사에서는 각 부문의 잠재적 수익 기회를 파악하고, 이 시장에서 매력적인 투자 제안 매트릭스에 대해 설명하고 있습니다.
- 또한, 본 조사에서는 시장 촉진요인, 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 그리고 주요 기업들이 채택하고 있는 경쟁 전략에 관한 중요한 인사이트를 제공합니다.
- 본 조사에서는 기업의 주요 정보, 제품 포트폴리오, 주요 성과, 재무 실적, 전략 등의 지표를 바탕으로 전 세계 마취 가스 시장의 주요 기업 개요을 작성하고 있습니다.
- 본 보고서의 인사이트를 활용함으로써, 기업의 마케팅 담당자 및 경영진은 향후 제품 출시, 제품 업그레이드, 시장 확대 및 마케팅 전략에 관해 정보에 기반한 의사결정을 내릴 수 있게 됩니다.
- 본 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 진입 기업, 금융 애널리스트 등 이 업계의 다양한 이해관계자를 대상으로 합니다.
- 이해관계자 여러분은 전 세계 마취 가스 시장 분석에 활용되는 다양한 전략 매트릭스를 통해 의사결정을 보다 수월하게 내릴 수 있을 것입니다.
목차
제1장 조사 목적과 가정
제2장 시장 전망
제3장 시장 역학·규제·동향 분석
제4장 세계의 마취 가스 시장 : 제품 유형별, 2021-2033년
제5장 세계의 마취 가스 시장 : 마취 가스별, 2021-2033년
제6장 세계의 마취 가스 시장 : 최종사용자별, 2021-2033년
제7장 세계의 마취 가스 시장 : 지역별, 2021-2033년
제8장 경쟁 구도
제9장 섹션
KSM 26.06.19Anesthesia Gases Market is estimated to be valued at USD 2,110.5 Mn in 2026 and is expected to reach USD 2,710.6 Mn by 2033, growing at a compound annual growth rate (CAGR) of 3.9% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 2,110.5 Mn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 3.90% | 2033 Value Projection: | USD 2,710.6 Mn |
Anesthetic gases (isoflurane, sevoflurane, desflurane, halothane, and nitrous oxide, among others), also known as inhaled anesthetics, are administered as a primary therapy for preoperative sedation and adjunctive anesthesia maintenance to intravenous (IV) anesthetic agents (such as midazolam and propofol) in the perioperative setting.
Market Dynamics
Increase in prevalence of chronic diseases, increase in geriatric (aging) population, rise in demand for anesthesia gases, increase in use of anesthesia during surgeries, and rise in number of surgical procedures around the world are major factors expected to propel growth of the global anesthesia gases market during the forecast period.
For instance, in February 2022, Sedana Medical announced the launch of Sedaconda (isoflurane) in Germany. Sedaconda (isoflurane), delivered via medical device Sedaconda ACD (Anaesthetic Conserving Device), is the only approved inhaled sedation therapy for use during intensive care. Sedaconda received European DCP approval in July 2021.
Key features of the study
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
- It profiles key players in the global anesthesia gases market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
- Key companies covered as a part of this study include Baxter, AbbVie Inc., Piramal Enterprises Ltd., Fresenius SE & Co. KgaA, Dragerwerk AG & Co. KgaA, GE Healthcare, and Mindray Medical International Limited, among others.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
- The global anesthesia gases market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global anesthesia gases market.
Market Segmentation
- By Product Type (Revenue, USD Mn, 2021-2033)
- Anesthesia Gases
- Vaporizer Devices
- By Anesthesia Gases (Revenue, USD Mn, 2021-2033)
- Desflurane
- Sevoflurane
- Isoflurane
- Nitrous Oxide
- Other Anesthesia Gases
- By End User (Revenue, USD Mn, 2021-2033)
- Hospital
- Ambulatory Surgical Centers
- By Region (Revenue, USD Mn, 2021-2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC
- Israel
- Rest of Middle East
- Africa
- South Africa
- Central Africa
- North Africa
- Competitive Landscape
- Baxter
- AbbVie Inc.
- Piramal Enterprises Ltd.
- Fresenius SE & Co. KgaA
- Dragerwerk AG & Co. KgaA
- GE Healthcare
- Mindray Medical International Limited
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Product Type
- Market Snapshot, By Anesthesia Gases
- Market Snapshot, By End User
- Market Snapshot, By Geography
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Increase in demand for or use of anesthesia gases
- Side effects of anesthesia gases
- Increase in number of surgical procedures
- Impact Analysis
- Key Highlights
- Regulatory Scenario
- Product launch/Approvals
- PEST Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
4. Global Anesthesia Gases Market, By Product Type, 2021-2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Anesthesia Gases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Vaporizer Devices
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
5. Global Anesthesia Gases Market, By Anesthesia Gases, 2021-2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Desflurane
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Sevoflurane
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Isoflurane
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Nitrous Oxide
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Other Anesthesia Gases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
6. Global Anesthesia Gases Market, By End User, 2021-2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Hospital
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Ambulatory Surgical Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
7. Global Anesthesia Gases Market, By Geography, 2021-2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Anesthesia Gases, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Mn)
- U.S.
- Canada
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Anesthesia Gases, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Mn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Anesthesia Gases, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Mn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Anesthesia Gases, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021-2033, (USD Mn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021-2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Anesthesia Gases, 2021-2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Mn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021-2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Anesthesia Gases, 2021-2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Mn)
- South Africa
- North Africa
- Central Africa
8. Competitive Landscape
- Baxter
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- AbbVie Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Piramal Enterprises Ltd.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Fresenius SE & Co. KgaA
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Dragerwerk AG & Co. KgaA
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- GE Healthcare
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Mindray Medical International Limited
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Analyst Views
9. Section
- Research Methodology
- About us
